While the United States remains a major market due to advanced research and telemedicine adoption (CAGR: 4.5%), Asia-Pacific ...

Lighthouse Pharmaceuticals’ plan to become a beacon of hope for Alzheimer’s disease patients has received almost $50 million ...

By Kami McDonald, Student Pharmacist and Karen L. Kier, Pharmacist ONU Healthwise Pharmacy ...

BioArctic AB (publ) (NASDAQ Stockholm: BIOA B) will publish the company's second quarter report for April - June 2025 on Thursday, August 28, 2025, at 08:00 a.m. CET.

Anne White, a 30-year company veteran who previously led the company’s oncology unit, will step down as head of Lilly ...

Kentucky advocates for people with Alzheimer’s are excited by new research showing that lifestyle interventions like ...

Dr. Curtis Schreiber led the study at CMH’s Missouri Memory Center, which was one of only 12 clinics nationwide selected to ...

On Friday, BIIB stock gained nearly 3%, bringing its trailing-five-day return to more than 5%. In the past month, BIIB has ...

In this video, Suzanne E. Schindler, MD, PhD, discusses the efficacy of both lecanemab (Leqembi, Eisai) and donanemab ...

As fans follow the health of singer and actor Justin Timberlake, his illness serves as a reminder of the importance of trying ...

Chinese authorities did not renew a conditional approval of Green Valley Pharmaceuticals’ controversial Alzheimer’s disease ...

Anavex Life Sciences Corp (AVXL) reports a robust financial runway and unveils encouraging results for blarcamesine, despite ...